CDMO insights podcast series: Our Experience is Your Strength | Episode #4 Commercial Launch
Once a drug receives regulatory approval, the clock starts ticking to get high-quality products packed, shipped, and available on the…
All articles by Miranda Mclaren
Miranda Mclaren
-
-
Top seven considerations when selecting primary packaging for injectable drugs
Between the start of 2022 and the end of 2024, GlobalData’s Drugs database recorded 160 US approvals for currently marketed…
-
CDMO insights podcast series: Our Experience is Your Strength | Episode #3 Clinical Forecasting, Packaging & Distribution
In the high-stakes world of clinical trials, timing is everything, but that doesn’t mean faster is always better. In the…
-
Meet the company on a mission to rewrite the cell therapy paradigm from South Texas
While major hurdles are still to be overcome, cell therapies have finally become a reality for certain cancers, and soon…
-
Exploring AI-powered cell simulations and the launch of the world’s first virtual lab
Artificial intelligence and machine learning (AI/ML) are fundamentally changing the world of drug discovery, enabling researchers to identify the potential…
-
Five considerations when scaling up mAbs in partnership with a CDMO
Scaling up production is a key stage in the lifetime of a monoclonal antibody (mAb), fraught with the risk of…
-
CDMO insights podcast series: Our Experience is Your Strength | Episode #2 Gene Therapy Fill-Finish
“You may design for 12 hours,” says Xufeng Sun, Vice President of Manufacturing Science & Technology at Sharp Sterile, “but…
-
Real-world evidence as a strategic access lever in rare disease drug development
More than 30 million people across Europe live with a rare disease, yet fewer than 5% of these conditions have…
-
Enhancing solubility of targeted protein degraders: Better strategies for bioavailability
Targeted protein degradation (TPD) represents a transformative approach within the field of therapeutic intervention, specifically for diseases where traditional small-molecule…
-
US trade tariffs and the potential impact on pharma supply chains
When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear,…